Lipid Management in Primary care

report from the EPCCS Summit 2026

View the discussion held at the EPCCS Summit held in Mallorca

Mar. 10, 2026

Lp(a): time to start measuring in primary care?

Designing the GP toolkit for dyslipidemia

Prof. Erik Stroes, Amsterdam, The Netherlands, provided a brief introduction on the emerging role of Lipoprotein (a) (Lp(a)), a genetic risk factor leading to an increased risk for cardiovascular disease. The introduction was followed by discussion with the EPCCS board and council members representing primary care from multiple European countries.

Mar. 10, 2026

Genetic Screening for FH: Rationale and experience

Designing the GP toolkit for dyslipidemia

Prof. Erik Stroes, Amsterdam, The Netherlands, provided an overview on the importance of cascade screening to detect Famiial Hypercholesterolemia (FH) and the lifetime benefits of early initiation of therapy. The introduction was followed by discussion with the EPCCS board and council members representing primary care from multiple European countries.

Mar. 9, 2026

Targets and treatments to manage LDL-c in primary care

Designing the GPtoolkit for Dyslipidaemia

Prof. Erik Stroes, Amsterdam, The Netherlands, provided a brief introduction on the management of LDL-cholesterol. He discussed LDL-c targets and most recent dyslipidemia guidelines and their implications for primary care. The introduction was followed by discussion with the EPCCS board and council members representing primary care from multiple European countries.